Correlation of prostatic specific antigen with Gleason grade in prostate cancer
Badalament, R.A.; Drago, J.R.
In Vivo 3(6): 381-382
1989
ISSN/ISBN: 0258-851X PMID: 2485141 Document Number: 334728
One hundred consecutive patients undergoing radical nerve-sparing prostatectomies and pelvic lymph node dissection were included in this study. These patients were treated from August 1985 through December 1986 at the Ohio State University Medical Center. Gleason grades 2, 3, and 4 patients had normal prostate specific antigens (PSA) preoperatively, except two, and Gleason grades 5, 6, and 7 had 50% elevated PSA's preoperatively. 76% of patients with Gleason grades 8, 9, and 10 had elevated PSA's preoperatively. It was concluded that PSA does correlated with Gleason grade.
Document emailed within 1 workday
Related Documents
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258Stenman, U.H.; Leinonen, J.; Alfthan, H.; Rannikko, S.; Tuhkanen, K.; Alfthan, O. 1991: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer Cancer Research 51(1): 222-226
Amayo, A.; Obara, W. 2004: Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate East African Medical Journal 81(1): 22-26
Yamaguchi, K.; Tanaka, M.; Kitagawa, N.; Kotake, T.; Yanagi, S.; Ito, H. 1989: The significance of serum prostate-specific antigen, gamma-seminoprotein and prostatic acid phosphatase as prostate cancer markers Hinyokika Kiyo. Acta Urologica Japonica 35(6): 987-991
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Ito, K.; Ohtake, N.; Hatori, M.; Mashimo, T.; Jimbo, S.; Tomaru, Y.; Makino, T.; Yajima, H.; Imai, K.; Yamanaka, H. 1992: Prostatic specific antigen (PA) in mass screening for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 38(11): 1225-1229
Walsh, P.C.; Oesterling, J.E.; Epstein, J.I.; Bruzek, D.J.; Rock, R.C.; Chan, D.W. 1989: The value of prostate-specific antigen in the management of localized prostatic cancer Progress in Clinical and Biological Research 303: 27-33
Sheth, A.R.; Garde, S.V.; Mehta, M.K.; Shah, M.G. 1992: Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide Indian Journal of Experimental Biology 30(3): 157-161
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Otnes, B.; Harvei, S.; Fosså, S.D. 1996: Increased incidence of prostatic cancer. the significance of prostate-specific antigen Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(15): 1795-1799
Mazo, E.B.; Sergeeva, N.A.; Grigor'ev, M.E.; Lebedev, D.V.; Solov'eva, E.V.; Konorev, V.A.; Krovets, A.A. 2006: Comparative value of molecular forms of prostate-specific antigen in diagnosis of prostatic cancer Urologiia 3: 21-24
Martínez de Hurtado, J.; Chéchile Toniolo, G.; Villavicencio Mavrich, H. 1995: The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 48(3): 247-259
Griniatsos, J.; Diamantis, E.; Gioti, J.; Karyda, I.; Vassilopoulos, P.P.; Agnanti, N. 1998: Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer Anticancer Research 18(1b): 683-688
Purnell, D.M.; Heatfield, B.M.; Trump, B.F. 1984: Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen Cancer Research 44(1): 285-292
Wen, R.; Zhao, W.L.; Wei, C.G.; Gu, Y.F.; Li, M.J.; Zhang, Y.Y.; Shen, J.K. 2019: Discussion of correlation between histogram analysis of quantitative diffusion weighted imaging and Gleason score of prostate cancer Zhonghua Yi Xue Za Zhi 99(11): 823-828
Patel, P.; Nayak, J.G.; Biljetina, Z.; Donnelly, B.; Trpkov, K. 2015: Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy Canadian Journal of Urology 22(6): 8056-8062
Bentvelsen, F.M.; Bogdanowicz, J.F.; Oosterom, R.; Schröder, F.H. 1990: A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma Nederlands Tijdschrift Voor Geneeskunde 134(33): 1596-1600
Mannini, D.; Aiello, E.; Maver, P.; Corrado, G.; Vecchi, F.; Bellanova, B. 1987: Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience Minerva Urologica e Nefrologica 39(4): 335-341
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Kamachi, S.; Sakurabayashi, I.; Kawai, T. 1984: Studies on prostate specific antigen, gamma-seminoprotein (gamma-Sm) as a tumor marker of prostatic cancer Rinsho Byori. Japanese Journal of Clinical Pathology 32(7): 781-785